Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Nature Chemical Biology
|
September 6, 2016
Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain
Gizem Akçay, Matthew A Belmonte, Brian Aquila, et al.
Chembiochem : a European Journal of Chemical Biology
|
August 4, 2015
Discovery and Characterization of New Hydroxamate Siderophores, Baumannoferrin A and B, produced by Acinetobacter baumannii
William F Penwell, Nancy DeGrace, Sharon Tentarelli, et al.
Journal of Medicinal Chemistry
|
November 14, 2024
Design and Synthesis of Acyclic Boronic Acid Arginase Inhibitors
Jason D Shields, Brian M Aquila, David Emmons, et al.
Journal of Medicinal Chemistry
|
April 26, 2021
Fragment-Based Design of a Potent MAT2a Inhibitor and <i>in Vivo</i> Evaluation in an MTAP Null Xenograft Model
Claudia De Fusco, Marianne Schimpl, Ulf Börjesson, et al.
Journal of Medicinal Chemistry
|
November 22, 2024
Discovery of (2<i>R</i>,4<i>R</i>)-4-((<i>S</i>)-2-Amino-3-methylbutanamido)-2-(4-boronobutyl)pyrrolidine-2-carboxylic Acid (AZD0011), an Actively Transported Prodrug of a Potent Arginase Inhibitor to Treat Cancer
Scott N Mlynarski, Brian M Aquila, Susan Cantin, et al.
Journal of Medicinal Chemistry
|
September 28, 2024
Optimization of Potent, Efficacious, Selective and Blood-Brain Barrier Penetrating Inhibitors Targeting EGFR Exon20 Insertion Mutations
Clare Thomson, Erin Braybrooke, Nicola Colclough, et al.
Molecular Cancer Therapeutics
|
March 13, 2023
Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners
Aatman S Doshi, Susan Cantin, Marylens Hernandez, et al.
Journal of Medicinal Chemistry
|
March 11, 2024
Development of a Series of Pyrrolopyridone MAT2A Inhibitors
Stephen J Atkinson, Sharan K Bagal, Argyrides Argyrou, et al.
Journal of Medicinal Chemistry
|
September 3, 2021
Optimization of an Imidazo[1,2-<i>a</i>]pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors with <i>In Vivo</i> Efficacy
William McCoull, Scott Boyd, Martin R Brown, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Nature Chemical Biology
|
September 6, 2016
Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain
Gizem Akçay, Matthew A Belmonte, Brian Aquila, et al.
Chembiochem : a European Journal of Chemical Biology
|
August 4, 2015
Discovery and Characterization of New Hydroxamate Siderophores, Baumannoferrin A and B, produced by Acinetobacter baumannii
William F Penwell, Nancy DeGrace, Sharon Tentarelli, et al.
Journal of Medicinal Chemistry
|
November 14, 2024
Design and Synthesis of Acyclic Boronic Acid Arginase Inhibitors
Jason D Shields, Brian M Aquila, David Emmons, et al.
Journal of Medicinal Chemistry
|
April 26, 2021
Fragment-Based Design of a Potent MAT2a Inhibitor and <i>in Vivo</i> Evaluation in an MTAP Null Xenograft Model
Claudia De Fusco, Marianne Schimpl, Ulf Börjesson, et al.
Journal of Medicinal Chemistry
|
November 22, 2024
Discovery of (2<i>R</i>,4<i>R</i>)-4-((<i>S</i>)-2-Amino-3-methylbutanamido)-2-(4-boronobutyl)pyrrolidine-2-carboxylic Acid (AZD0011), an Actively Transported Prodrug of a Potent Arginase Inhibitor to Treat Cancer
Scott N Mlynarski, Brian M Aquila, Susan Cantin, et al.
Journal of Medicinal Chemistry
|
September 28, 2024
Optimization of Potent, Efficacious, Selective and Blood-Brain Barrier Penetrating Inhibitors Targeting EGFR Exon20 Insertion Mutations
Clare Thomson, Erin Braybrooke, Nicola Colclough, et al.
Molecular Cancer Therapeutics
|
March 13, 2023
Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners
Aatman S Doshi, Susan Cantin, Marylens Hernandez, et al.
Journal of Medicinal Chemistry
|
March 11, 2024
Development of a Series of Pyrrolopyridone MAT2A Inhibitors
Stephen J Atkinson, Sharan K Bagal, Argyrides Argyrou, et al.
Journal of Medicinal Chemistry
|
September 3, 2021
Optimization of an Imidazo[1,2-<i>a</i>]pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors with <i>In Vivo</i> Efficacy
William McCoull, Scott Boyd, Martin R Brown, et al.
Page
of 2